Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-12-29 to 2023-01-09
Current total value of award: $16.1
Description: 8509614551!MECLIZINE HYDROCHLO